IMPAVIDO (Profounda, Inc.)
Welcome to the PulseAid listing for the IMPAVIDO drug offered from Profounda, Inc.. This Antileishmanial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Profounda, Inc. |
NON-PROPRIETARY NAME: | miltefosine |
SUBSTANCE NAME: | MILTEFOSINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antileishmanial [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-10-29 |
END MARKETING DATE: | 0000-00-00 |
IMPAVIDO HUMAN PRESCRIPTION DRUG Details:
Item Description | IMPAVIDO from Profounda, Inc. |
LABELER NAME: | Profounda, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2015-10-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69051-300_bcb387ac-2e90-4f5e-94b2-d3635190678e |
PRODUCT NDC: | 69051-300 |
APPLICATION NUMBER: | NDA204684 |
Other MILTEFOSINE Pharmaceutical Manufacturers / Labelers: